EQS Newswire is a major provider of regulatory and corporate news. It mainly serves companies, investors and media worldwide. Through its services, EQS Newswire enables efficient and secure communication between companies and their stakeholders. Its main services include the distribution of ad hoc announcements, corporate news and the publication of financial reports that meet strict international standards.
Fri, 14.03.2025
BioVersys AG
/ Key word(s): Annual Results
BIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS 14.03.2025 / 07:00 CET/CEST
Basel, Switzerland. March 14, 2025, 7am CET
BioVersys AG (SIX: BIOV), a multi-asset, clinical stage biopharmaceutical company focusing on research and development of ...
Ad hoc announcement pursuant to Art. 53 LR
Basel, Switzerland. March 10, 2025, 7am CET. Ad hoc announcement pursuant to Art. 53 LR
Partial exercise of over-allotment option following end of stablization period in context of the company’s initial public offering (IPO)
An additional 47,862 new shares to be issued by BioVersys
BioVersys raised tot...
BioVersys AG
/ Key word(s): Miscellaneous
BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE 11.02.2025 / 07:00 CET/CEST
Basel, Switzerland. February 11, 2025, 7am CET
BV500 reaches second milestone, with the advancement of multiple broadly profiled and highly potent oral Lead c...
BioVersys AG
/ Key word(s): IPO
BIOVERSYS SUCCESSFULLY COMPLETES ITS IPO AT CHF 36 PER SHARE AND STARTS TRADING ON THE SIX SWISS EXCHANGE TOMORROW, FEBRUARY 07, 2025 06.02.2025 / 07:00 CET/CEST
__________
THIS IS A RESTRICTED COMMUNICATION AND YOU MUST NOT FORWARD IT OR ITS CONTENTS TO ANY PERSON TO WHOM FORWARDING THIS COMMU...
You have pressed the "". We would like to inform you that you are now leaving the information service of the portal site ayondo.com. You will be redirected to . After confirming the "Continue" button, you confirm that you have been informed of this. You also confirm that you are carrying out this process of your own free will and that it is not the result of any promotional activity or other influence. Continue to .